Post by Vertex Pharmaceuticals on X
Vertex Pharmaceuticals@VertexPharma
X#Breaking: The U.S. FDA has accepted the application and granted Priority Review for our fifth investigational CFTR modulator #CysticFibrosis. Learn more: t.co
61 likes4 repliesPosted Jul 2, 2024